Published in BMC Cancer on August 06, 2010
Heat shock protein 90 (hsp90) expression and breast cancer. Pharmaceuticals (Basel) (2012) 0.81
An optimized, broadly applicable piggyBac transposon induction system. Nucleic Acids Res (2017) 0.75
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. Int J Mol Sci (2017) 0.75
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol (1999) 11.18
Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci (2007) 3.74
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer (1996) 2.95
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study. J Clin Oncol (2007) 2.80
Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol (2005) 2.30
Heat shock proteins as emerging therapeutic targets. Br J Pharmacol (2005) 2.25
Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther (2004) 2.16
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr Relat Cancer (2006) 2.11
Hsp90: a novel target for cancer therapy. Curr Top Med Chem (2006) 1.93
High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res (2007) 1.88
Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies. Mol Cell Biol (1984) 1.71
Hsp90: an emerging target for breast cancer therapy. Anticancer Drugs (2004) 1.64
Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res (2008) 1.48
Do heat shock proteins have a role in breast cancer? Br J Cancer (1996) 1.17
Expression and roles of heat shock proteins in human breast cancer. Jpn J Cancer Res (1996) 1.15
Expression of hsp90 and cyclin D1 in human breast cancer. Cancer Lett (1999) 1.13
Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents. Curr Pharm Des (2005) 1.11
Heat shock proteins: a review of the molecular chaperones. J Vasc Surg (1999) 1.10
Identification of new biomarkers for clinical trials of Hsp90 inhibitors. Mol Cancer Ther (2006) 1.10
Precursor lesions of invasive breast cancer. Eur J Radiol (2005) 1.00
Elevated expression of nuclear Hsp90 in invasive breast tumors. Cancer Biol Ther (2009) 0.89
MHC-class-I expression in human breast cancer correlates with nuclear localization of the 90 kDa heat-shock-protein. Anticancer Res (2000) 0.87
Heat shock protein90 in lobular neoplasia of the breast. BMC Cancer (2008) 0.81
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol (2010) 5.65
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol (2005) 4.69
Gastrointestinal stromal tumor. World J Surg Oncol (2009) 2.05
Primary aldosteronism in hypertensive patients: clinical implications and target therapy. Eur J Clin Invest (2014) 1.99
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Breast Cancer Res Treat (2008) 1.82
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy. Cancer (2010) 1.71
Actinomycosis of the appendix and pelvis: a case report. J Reprod Med (2008) 1.58
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care (2010) 1.55
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study. Eur J Cancer (2008) 1.43
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Mirizzi Syndrome: an unexpected problem of cholelithiasis. Our experience with 27 cases. Int Semin Surg Oncol (2008) 1.27
Clinical considerations and therapeutic strategy for sigmoid volvulus in the elderly: a study of 33 cases. World J Gastroenterol (2007) 1.27
Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg (2006) 1.26
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Self-locking first stitch in suture reinforcement of the laparoscopic gastric sleeve. Obes Surg (2013) 1.20
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease. World J Gastroenterol (2009) 1.17
Embryonal rhabdomyosarcoma of the uterine cervix. Clin Transl Oncol (2009) 1.12
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer (2009) 1.11
Unusual site of recurrent musculoskeletal hydatid cyst: case report and brief review of the literature. World J Gastroenterol (2006) 1.09
A mixability theory for the role of sex in evolution. Proc Natl Acad Sci U S A (2008) 1.08
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial. Breast Cancer Res Treat (2011) 1.05
EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells. Int J Biochem Cell Biol (2012) 1.05
Application of the pedicled anterolateral thigh flap to defects from the pelvis to the knee. Microsurgery (2006) 1.04
Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report. World J Surg Oncol (2007) 1.04
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res (2010) 1.02
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
Analysis of PRNP gene codon 129 polymorphism in the Greek population. Eur J Epidemiol (2006) 1.01
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat (2012) 1.01
Delorme's procedure revisited for an incarcerated transverse loop colostomy prolapse repair. Am Surg (2013) 1.00
Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. Virchows Arch (2004) 1.00
E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res (2004) 1.00
Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol (2007) 1.00
Reinforcing the staple line during laparoscopic sleeve gastrectomy: prospective randomized clinical study comparing two different techniques. Preliminary results. Obes Surg (2012) 0.99
Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma. Int Surg (2007) 0.99
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97
Granulosa cell tumor of the ovary: tumor review. Integr Cancer Ther (2008) 0.96
Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res (2005) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Presence of MUC4 in human milk and at the luminal surfaces of blood vessels. J Cell Physiol (2005) 0.95
Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis (2010) 0.95
Muc4/MUC4 functions and regulation in cancer. Future Oncol (2009) 0.95
Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism (2011) 0.95
Primary melanoma of the gallbladder: does it exist? Report of a case and review of the literature. World J Gastroenterol (2006) 0.95
Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast Cancer Res Treat (2013) 0.94
Thyroid surgery with the new harmonic scalpel: a prospective randomized study. Surgery (2010) 0.93
Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article. Molecules (2009) 0.93
Transanal polypectomy using single incision laparoscopic instruments. World J Gastrointest Surg (2011) 0.92
Malignant carcinoid tumor of the cystic duct: a rare cause of bile duct obstruction. Hepatobiliary Pancreat Dis Int (2009) 0.92
Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor. Int Semin Surg Oncol (2009) 0.92
Sex, mixability, and modularity. Proc Natl Acad Sci U S A (2010) 0.92
Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncol Rep (2011) 0.92
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid. Transl Res (2010) 0.92
Morbid obesity and sleeve gastrectomy: how does it work? Obes Surg (2010) 0.92
ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World J Surg Oncol (2012) 0.91
C-reactive protein, white blood cells, and neutrophils as early predictors of postoperative complications in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc (2012) 0.91
High-level microsatellite instability is not involved in gallbladder carcinogenesis. Exp Mol Pathol (2005) 0.91
Clinical implications of sleeve gastrectomy as a source of spleen infarction or ischemia. Obes Surg (2011) 0.91
Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives. Asian Pac J Cancer Prev (2011) 0.91
Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol (2012) 0.91
All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer. Cancer Treat Rev (2010) 0.91
Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications. Cancer Treat Rev (2011) 0.91
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide. Leuk Lymphoma (2003) 0.91
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer. Urology (2011) 0.91
Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90
Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas. Histopathology (2010) 0.90
High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol (2007) 0.90
Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother Pharmacol (2008) 0.90
Routine abdominal drains after laparoscopic sleeve gastrectomy: a retrospective review of 353 patients. Obes Surg (2011) 0.89
Long-term plasma ghrelin and leptin modulation after sleeve gastrectomy in Wistar rats in comparison with gastric tissue ghrelin expression. Obes Surg (2011) 0.89
Prognostic significance of phosphorylated STAT-1 expression in premenopausal and postmenopausal patients with invasive breast cancer. Histopathology (2012) 0.89
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation. Anticancer Res (2011) 0.89
HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. Mol Biol Rep (2012) 0.88
Hematoma after vacuum-assisted breast biopsy: are interleukins predictors? Onkologie (2009) 0.88
Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas (2010) 0.88
Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4. Clin Exp Metastasis (2014) 0.88
Coexistence of tumor-induced osteomalacia and primary hyperparathyroidism. Endocr Pract (2011) 0.87
Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: an experimental study. Atherosclerosis (2007) 0.87
Mesenteric ischemia: still a deadly puzzle for the medical community. Tohoku J Exp Med (2008) 0.87
Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther (2009) 0.86
Postoperative pulmonary function after open abdominal aortic aneurysm repair in patients with chronic obstructive pulmonary disease: epidural versus intravenous analgesia. Ann Vasc Surg (2011) 0.86
Corticomedullary mixed adrenal tumor: case report and literature review. Endocr J (2009) 0.86
Secondary breast lymphoma diagnosed by vacuum-assisted breast biopsy: a case report. J Med Case Rep (2007) 0.86
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients. Int J Cancer (2014) 0.86
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer (2005) 0.86
Expression of clock genes in patients with colorectal cancer. Int J Biol Markers (2013) 0.86
Ductal endoscopy of the breast: more painful at the luteal phase? Pain Pract (2009) 0.86
Is early laparoscopic cholecystectomy for acute cholecystitis preferable to delayed surgery?: Best evidence topic (BET). Int J Surg (2012) 0.86
Esophageal Doppler (ODM II) improves intraoperative hemodynamic monitoring during laparoscopic surgery. Surg Laparosc Endosc Percutan Tech (2005) 0.86
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression. Anticancer Res (2014) 0.86
Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast (2012) 0.86
Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome. Anticancer Res (2007) 0.85